Gelatinases A and B are expressed in late lesions in autoimmune bullous disorders

被引:0
|
作者
Feliciani, C
Toto, P
Coscione, G
Pour, SM
Allegretti, T
Proietto, G
Amerio, P
机构
关键词
collagenases; gelatinases; pemphigus; re-epithelization;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gelatinases (or metalloproteinase off collagenases) are involved in remodelling the extracellular matrix in several skin disorders, Previous reports show that the 72 kDa (Gelatinase A), the 92 kDa collagenase (Gelatinase B) and their inhibitors TIMP-2 and TIMP-1 respectively are overexpressed in tumor invasion and metastasis, granuloma annulare, necrobiosis lipoidica diabeticorum and bullous pemphigoid. Usually their natural inhibitors, TIMP-1 and TIMP-2, are inversely related to the production of the 72kDa and 92kDa proteins. 8 patients affected by Bullous Pemphigoid (BP) and 8 patients affected by Pemphigus Vulgaris (PV) were biopsized in perilesional areas of young lesions and in lesional areas of old lesions. Materials were snap frozen in liquid nitrogen until use. Antibodies to 72kDa, 92kDa, TIMP-1, TIMP-2, CD44, laminin, collagen type I, III, IV, VII were used and evidentiated by the avidin-biotin immunoperoxidase tecnique, mRNA expression for Gelatinases and their inhibitors were also analyzed by RT-PCR. In all patients we found gelatinases expression only in the late lesions. A different expression was found between the two diseases, the 92 kDa protein and its inibitor TIMP-1 were positive in both PB and PV whereas the 72kDa form and its inhibitor TIMP-2 were evident only in PB. By RT-PCR we show that the 72 kDa mRNA was expressed exclusively in the dermis, on the contrary the 92 kDa was present in epidermis and dermis. No signals were detected in the early phase of blistering suggesting a role of gelatinases in re-epithelization but not in blistering where other proteases play a major role. The differential expression of Gelatinases and their inhibitors is probably under a cytokine network control.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 50 条
  • [41] Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease - specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires
    Kalinska-Bienias, Agnieszka
    Jakubowska, Beata
    Kowalewski, Cezary
    Murrell, Dedee F.
    Wozniak, Katarzyna
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (01): : 92 - 96
  • [42] Interleukin-10-producing B-cells in autoimmune bullous diseases
    Hashimoto, T.
    Mizoguchi, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (05) : 1119 - 1120
  • [43] The preparation of dermal and epidermal protein extracts for the detection of autoimmune bullous disorders using an immunoblotting technique
    Boersma, AM
    Pas, HH
    Kloosterhuis, GJ
    Kemp, MW
    Kossard, S
    Martin, L
    Murrell, DF
    Jonkman, MF
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (06) : A12 - A12
  • [44] Involvement of cytotoxic proteins such as TIA-1 and granzyme B in autoimmune bullous dermatoses
    Vuille, N
    Brönnimann, M
    Kappeler, A
    Braathen, LR
    Yawalkar, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A14 - A14
  • [45] GROUP-B STREPTOCOCCUS AS A CAUSE OF NEONATAL BULLOUS SKIN-LESIONS
    KLINE, A
    ODONNELL, E
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (02) : 165 - 166
  • [46] B Cell Reconstitution Following Rituximab in Autoimmune Disorders
    Patel, P. D.
    Rubinstein, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB215 - AB215
  • [47] B cells as therapeutic targets in autoimmune neurological disorders
    Dalakas, Marinos C.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (10): : 557 - 567
  • [48] THE OCCURRENCE OF MONOCYTOID B-LYMPHOCYTES IN AUTOIMMUNE DISORDERS
    AOZASA, K
    OHSAWA, M
    HORIUCHI, K
    SAEKI, K
    KATAYAMA, S
    MATSUZUKA, F
    YAMAMURA, T
    MODERN PATHOLOGY, 1993, 6 (02) : 121 - 124
  • [49] B cells as therapeutic targets in autoimmune neurological disorders
    Marinos C Dalakas
    Nature Clinical Practice Neurology, 2008, 4 : 557 - 567
  • [50] CD1b is expressed in multiple sclerosis lesions
    Battistini, L
    Fischer, FR
    Raine, CS
    Brosnan, CF
    JOURNAL OF NEUROIMMUNOLOGY, 1996, 67 (02) : 145 - 151